---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-017363"
form_type: "8-K"
ticker: "BMRA"
cik: "0000073290"
company_name: "BIOMERICA INC"
filed_at: "2025-10-08T23:59:59+00:00"
generated_at: "2026-05-17T04:22:32.881964+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Biomerica appoints former LabCorp Diagnostics CEO Gary Huff to board; director Emerson not standing for re-election

## Summary
- Gary Huff appointed as independent director effective Oct 7, 2025; will serve on Audit, Comp, and Governance committees.
- Huff receives annualized cash fee of $45,000 (paid quarterly); no equity compensation granted for board appointment.
- Dr. Jane Emerson to step down after 18 years on board, not seeking re-election at Dec 12, 2025 annual meeting; board size to reduce to 5.
- Huff brings 35+ years of lab industry experience, having served as CEO of LabCorp Diagnostics and Baylor Genetics.

## SEC filing metadata
- accession: 0001493152-25-017363
- form_type: 8-K
- ticker: BMRA
- cik: 0000073290
- company_name: BIOMERICA INC
- filed_at: 2025-10-08T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/73290/000149315225017363/0001493152-25-017363-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/73290/000149315225017363/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-017363
- JSON: https://secwatch.observer/filing/0001493152-25-017363.json
- Plain text: https://secwatch.observer/filing/0001493152-25-017363.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.